Clorox (CLX) official guidance

I would consider ex GOJO, where we're spending over 11% of sales as we have in the past number of years, where we increased it from 10%, to continue.

So the 10% reflects GOJO's lower percent of advertising and sales promotion.

We expect the categories to continue to be muted given what's going on from a macroeconomic perspective and consumers continuing to engage in value-seeking behaviors, largely consistent with what we saw in 2026.

In fiscal year 2027, we expect another year of strong cash flow generations. That should be in line with our targeted range of 11%-13%.

We expect them to be accretive to adjusted EPS as well next fiscal year.

When it is about 42%, there's a little bit of movement, and the EPS is quite sensitive.

When you net all of that, we expect to start recovering gross margin in the back half.

We expect fiscal year 2027 inflation to be above $200 million.

We expect the impact of the inflation to be more pronounced in the first half of fiscal year 2027.

Right now it's about $210 million.

We expect to continue to make progress throughout the course of the fiscal year on market share, and that gets us to the combination of what we expect from an organic growth perspective.

Our outlook assumes an average for Brent crude oil at about $90 per barrel.

Going forward, though, we fully expect this business to continue growing at mid-single digits, and we expect to start seeing some of the revenue synergies showing up as early as next year.

First and foremost, the 16% of sales includes about 40 basis points of negative impact from GOJO transaction-related costs.

(1)In fiscal year 2027, the company expects to incur approximately $46 ($35 after tax) of costs related to the GOJO acquisition.

•The company's effective tax rate is expected to be about 23%.

•Diluted EPS is expected to be between $5.41 and $5.71, a year-over-year increase of 12% to 19%, respectively. This includes about 29 cents of impact from transaction-related costs associated with the GOJO acquisition, which are expected to flow through cost of goods sold as well as selling and administrative expenses.

•Adjusted EPS is expected to be between $5.70 and $6.00, or an increase between 3% and 8%, respectively. These growth rates include the benefit of lapping the inventory drawdown related to the ERP transition in the prior year.

•Net sales are expected to be up 13% to 14% compared to the prior year, including about 9.5 points of benefit from the GOJO acquisition. Organic sales are expected to increase about 3.5% to 4.5%, including more than 3.5 points of benefit from lapping the ERP-related drawdown in the prior fiscal year.

•Net sales are expected to be up 13% to 14% compared to the prior year, including about 9.5 points of benefit from the GOJO acquisition. Organic sales are expected to increase about 3.5% to 4.5%, including more than 3.5 points of benefit from lapping the ERP-related drawdown in the prior fiscal year.